BioCentury
ARTICLE | Financial News

DBV sets terms for dual listing

October 21, 2014 2:38 AM UTC

DBV Technologies (Euronext:DBV) finalized the details of its planned global offering of shares that will include a dual-listing of ADSs on NASDAQ.

The allergy specialist now plans to sell up to 2.7 million ordinary shares, with each ADS representing one-half of an ordinary share. DBV's orginal SEC filing called for the sale of up to 3 million shares, with each ADS representing one ordinary share. ...